1 Barnes, P. J. & Celli, B. R. Systemic manifestations and comorbidities of COPD. Eur Respir J 33, 1165-1185, doi:10.1183/09031936.00128008 (2009).
2 Centers for Disease Control and Prevention: Leading Causes of Death, http://www.cdc.gov/nchs/fastats/leading-causes-of-death.html , published/last updated October 7, 2016 (Accessed on 03/17/2017). (2017).
3 Lopez-Campos, J. L., Tan, W. & Soriano, J. B. Global burden of COPD. Respirology 21, 14-23, doi:10.1111/resp.12660 (2016).
4 Dunsmore, S. E. Treatment of COPD: a matrix perspective. Int J Chron Obstruct Pulmon Dis 3, 113-122 (2008).
5 Vogelmeier, C. F. et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med 195, 557-582, doi:10.1164/rccm.201701-0218PP (2017).
6 Turato, G., Zuin, R. & Saetta, M. Pathogenesis and pathology of COPD. Respiration 68, 117-128, doi:10.1159/000050478 (2001).
7 Ning, W. et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proceedings of the National Academy of Sciences of the United States of America 101, 14895-14900, doi:10.1073/pnas.0401168101 (2004).
8 Ezzie, M. E. et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax 67, 122-131, doi:10.1136/thoraxjnl-2011-200089 (2012).
9 Mostafaei, S. et al. Identification of Novel Genes in Human Airway Epithelial Cells associated with Chronic Obstructive Pulmonary Disease (COPD) using Machine-Based Learning Algorithms. Scientific reports 8, 15775, doi:10.1038/s41598-018-33986-8 (2018).
10 Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nature reviews. Genetics 10, 57-63, doi:10.1038/nrg2484 (2009).
11 Ozsolak, F. & Milos, P. M. RNA sequencing: advances, challenges and opportunities. Nature reviews. Genetics 12, 87-98, doi:10.1038/nrg2934 (2011).
12 Mele, M. et al. Human genomics. The human transcriptome across tissues and individuals. Science 348, 660-665, doi:10.1126/science.aaa0355 (2015).
13 Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nature genetics 45, 580-585, doi:10.1038/ng.2653 (2013).
14 Rosenbaum, P. R. Optimal matching for observational studies. Journal of the American Statistical Association 84, 1024-1032 (1989).
15 Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882-883, doi:10.1093/bioinformatics/bts034 (2012).
16 Braber, S. et al. An association between neutrophils and immunoglobulin free light chains in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185, 817-824, doi:10.1164/rccm.201104-0761OC (2012).
17 Redegeld, F. A. et al. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nature medicine 8, 694-701, doi:10.1038/nm722 (2002).
18 Heijink, I. H., Brandenburg, S. M., Postma, D. S. & van Oosterhout, A. J. Cigarette smoke impairs airway epithelial barrier function and cell-cell contact recovery. Eur Respir J 39, 419-428, doi:10.1183/09031936.00193810 (2012).
19 Aghapour, M., Raee, P., Moghaddam, S. J., Hiemstra, P. S. & Heijink, I. H. Airway Epithelial Barrier Dysfunction in Chronic Obstructive Pulmonary Disease: Role of Cigarette Smoke Exposure. Am J Respir Cell Mol Biol 58, 157-169, doi:10.1165/rcmb.2017-0200TR (2018).
20 Fabregat, A. et al. The Reactome pathway Knowledgebase. Nucleic Acids Res 44, D481-487, doi:10.1093/nar/gkv1351 (2016).
21 Skronska-Wasek, W. et al. Reduced Frizzled Receptor 4 Expression Prevents WNT/beta-Catenin-driven Alveolar Lung Repair in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 196, 172-185, doi:10.1164/rccm.201605-0904OC (2017).
22 Heijink, I. H. et al. Role of aberrant WNT signalling in the airway epithelial response to cigarette smoke in chronic obstructive pulmonary disease. Thorax 68, 709-716, doi:10.1136/thoraxjnl-2012-201667 (2013).
23 Konings, G. F. J. et al. Increased levels of enzymes involved in local estradiol synthesis in chronic obstructive pulmonary disease. Mol Cell Endocrinol 443, 23-31, doi:10.1016/j.mce.2016.12.001 (2017).
24 Choi, J. S. et al. Array CGH reveals genomic aberrations in human emphysema. Lung 187, 165-172, doi:10.1007/s00408-009-9142-x (2009).
25 Farid, M. et al. Smad3 mediates cigarette smoke extract (CSE) induction of VEGF release by human fetal lung fibroblasts. Toxicol Lett 220, 126-134, doi:10.1016/j.toxlet.2013.04.011 (2013).
26 Semenza, G. L. Pulmonary vascular responses to chronic hypoxia mediated by hypoxia-inducible factor 1. Proc Am Thorac Soc 2, 68-70, doi:10.1513/pats.200404-029MS (2005).
27 Sun, N. N., Wei, X. F., Wang, J. L., Cheng, Z. Z. & Sun, W. H. Caveolin-1 Promotes the Imbalance of Th17/Treg in Patients with Chronic Obstructive Pulmonary Disease. Inflammation 39, 2008-2015, doi:10.1007/s10753-016-0436-x (2016).
28 Ito, K. et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352, 1967-1976, doi:10.1056/NEJMoa041892 (2005).
29 Brody, J. S. & Steiling, K. Interaction of cigarette exposure and airway epithelial cell gene expression. Annu Rev Physiol 73, 437-456, doi:10.1146/annurev-physiol-012110-142219 (2011).
30 Sopori, M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2, 372-377, doi:10.1038/nri803 (2002).
31 Pauwels, R. A. & Rabe, K. F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364, 613-620, doi:10.1016/S0140-6736(04)16855-4 (2004).
32 Salvi, S. S. & Barnes, P. J. Chronic obstructive pulmonary disease in non-smokers. Lancet 374, 733-743, doi:10.1016/S0140-6736(09)61303-9 (2009).
33 McCall, M. N., Illei, P. B. & Halushka, M. K. Complex Sources of Variation in Tissue Expression Data: Analysis of the GTEx Lung Transcriptome. American journal of human genetics 99, 624-635, doi:10.1016/j.ajhg.2016.07.007 (2016).
34 Baslan, T. & Hicks, J. Unravelling biology and shifting paradigms in cancer with single-cell sequencing. Nat Rev Cancer 17, 557-569, doi:10.1038/nrc.2017.58 (2017).
35 Kolodziejczyk, A. A., Kim, J. K., Svensson, V., Marioni, J. C. & Teichmann, S. A. The technology and biology of single-cell RNA sequencing. Mol Cell 58, 610-620, doi:10.1016/j.molcel.2015.04.005 (2015).
36 Mele, M. et al. The human transcriptome across tissues and individuals. Science 348, 660-665, doi:10.1126/science.aaa0355 (2015).
37 Ho, D. E., Imai, K., King, G. & Stuart, E. A. MatchIt: Nonparametric Preprocessing for Parametric Causal Inference. J Stat Softw 42 (2011).
38 Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome biology 15, doi:ARTN 550
10.1186/s13059-014-0550-8 (2014).
39 Yu, G. C., Wang, L. G., Han, Y. Y. & He, Q. Y. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. Omics 16, 284-287, doi:10.1089/omi.2011.0118 (2012).
40 Bindea, G. et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25, 1091-1093, doi:10.1093/bioinformatics/btp101 (2009).
41 Xia, J. G., Gill, E. E. & Hancock, R. E. W. NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data. Nature Protocols 10, 823-844, doi:10.1038/nprot.2015.052 (2015).
42 Szklarczyk, D. et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 45, D362-D368, doi:10.1093/nar/gkw937 (2017).
43 Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research 43, doi:ARTN e47
10.1093/nar/gkv007 (2015).
44 Bauer, Y. et al. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 52, 217-231, doi:10.1165/rcmb.2013-0310OC (2015).